What Boehringer Ingelheim Pharmaceuticals, Inc. pays on H-1B filings
Boehringer Ingelheim Pharmaceuticals, Inc. filed 66 certified H-1B LCAs in FY2025-FY2026. Each one states the wage the employer will pay for a role at a worksite. Grouped by title below: what the employer stated, not what any one person earned.
FY2026 so far · 26 LCAsFY2025 · 40 LCAs
Stated wages by title
| Title | LCAs | Year | Typical range | Median |
|---|---|---|---|---|
| Clinical Data Scientist | 10 | FY2026 so far | $148,748 to $164,223 | $157,903 |
| Scientist | 10 | FY2026 so far | $140,500 to $145,000 | $142,000 |
| Associate Director | 6 | FY2026 so far | $173,825 to $181,515 | $177,727 |
| Scientist Process Research | 6 | FY2025 | $128,000 to $157,524 | $130,000 |
| Post Doctoral Iu Fellow | 4 | FY2026 so far | $80,000 to $81,250 | $80,000 |
| Post Doctoral Fellow | 3 | FY2025 | $80,000 | $80,000 |
Typical range is the middle half of that year's filings, or the full span when there are fewer than four. LCA counts cover FY2025-FY2026.
Filings by fiscal year
| Fiscal year | Certified LCAs |
|---|---|
| FY2026 (October to June) | 26 |
| FY2025 | 40 |
By prevailing-wage level
| Level | LCAs | Median stated wage |
|---|---|---|
| Level I (entry) | 4 | $80,000 |
| Level II (qualified) | 19 | $130,000 |
| Level III (experienced) | 12 | $156,755 |
| Level IV (fully competent) | 30 | $168,138 |
| No level stated | 1 | $151,621 |
DOL sets four prevailing-wage levels for each job and place, from entry (I) to fully competent (IV). The level is the employer's own classification of the position.
Top worksites
| Worksite | LCAs | Median stated wage |
|---|---|---|
| Ridgefield, CT | 47 | $155,920 |
| Danbury, CT | 1 | $150,000 |
Looking at Boehringer Ingelheim Pharmaceuticals, Inc.?
Nyanza shows these filings next to any posting you check, with the employer's H-1B approval history, so you can ask the right questions early.